The Informed Consent Frontier: Patient Rights in AI-Assisted Care

AI in healthcare is growing fast, but patient consent processes are struggling to keep up. Here's what you need to know:

• AI complicates consent: Patients often can't grasp how AI works, making true informed consent difficult. For example, when NYU Langone Health disclosed data storage details, consent rates dropped from 81.6% to 55.3%.
• Bias risks: AI systems can reinforce inequalities. A 2019 study showed a healthcare algorithm underestimated the needs of Black patients, affecting care decisions.
• Legal gaps: U.S. regulations are fragmented, with state laws like Texas SB 1188 and California AB 3030 requiring AI disclosure but lacking consistency.
• Human oversight isn't foolproof: Automation bias can lead clinicians to over-rely on AI, risking errors.
• Solutions: Dynamic consent models, clear communication, and clinician training can help restore trust and protect patient rights.

AI's potential is huge, but patient autonomy must remain at the center. Transparency, accountability, and better risk management are key to ensuring ethical AI use in healthcare.

Challenges to Patient Autonomy in AI-Assisted Care

Making AI Algorithms Understandable to Patients

The "black-box" problem creates a major roadblock to informed consent. Many AI systems operate in ways that even physicians struggle to explain. If a doctor can’t clearly articulate how an AI reached a decision or pinpoint where it might go wrong, patients are left without the full picture needed to make informed choices about their care.

Interestingly, surveys show that patients care more about practical outcomes than technical specifics. In one study, patients rated the importance of understanding the "architecture of the AI tool" at 5.59 out of 7, while the "side effects of the procedure" scored higher at 6.11 ^[5]. This suggests that doctors should focus on communicating the AI's purpose and effectiveness rather than diving into technical jargon. For instance:

This software helps me detect early signs of diabetic retinopathy that might be hard to spot with the human eye. In studies, it achieved a sensitivity of about 87% ^[9].

Transparency is key, as 63% of patients want to be informed when AI is involved in their care ^[4]. But clarity is just as important - patients need meaningful, straightforward explanations. Beyond understanding how the AI works, ensuring its decisions are carefully verified is critical to maintaining trust.

Maintaining Human Oversight in Automated Decisions

While clear explanations of AI tools are essential, they must go hand in hand with strong human oversight to catch errors. However, relying solely on human oversight isn’t foolproof. A common issue, known as automation bias, complicates this safeguard. Automation bias occurs when clinicians overly trust AI recommendations, even when they’re wrong. This can lead to two types of errors: acting on incorrect AI predictions (commission errors) or ignoring mistakes made by the AI (omission errors) ^[10].

The challenges don’t stop there. A 2025 survey revealed that only 8% of healthcare organizations feel "very confident" in identifying new AI risks, and just over half have formal approval processes in place before rolling out AI tools ^[1]. Without robust technical oversight, monitoring AI performance often becomes a surface-level task. To address this, healthcare organizations need to build real technical expertise and train clinicians on the strengths, limitations, and evidence behind each AI tool they use.

Managing Bias and Equity in AI Systems

Clarity and oversight are crucial, but tackling bias is equally important to ensure fair care for all patients. AI bias can seriously undermine patient autonomy and equitable treatment. A 2023 analysis of 48 healthcare AI studies found that half had a high risk of bias, often due to imbalanced datasets or missing sociodemographic data. Only 20% of the studies were deemed low risk ^[10].

The impact of this bias is stark. For example, a 2019 study examined a widely used U.S. healthcare risk-prediction algorithm. It analyzed data from 43,539 White patients and 6,079 Black patients. By using historical healthcare costs as a proxy for illness severity, the algorithm undervalued the needs of Black patients. At the same risk score, Black patients had 26.3% more chronic illnesses than White patients. Recalibrating the model to use direct health indicators instead of costs nearly tripled the identification of high-risk Black patients for care management - from 17.7% to 46.5% ^[10].

Bias isn’t limited to one area. In a review of 555 neuroimaging-based AI models for psychiatric diagnoses, 83% were rated as high risk of bias, and 97.5% only included participants from high-income regions ^[10]. Fixing these issues requires action at every stage of the AI process - from data collection and development to deployment and monitoring. Regularly evaluating AI performance across diverse patient groups is essential. Including voices from marginalized communities in the development process can also help ensure that AI reflects a broader range of experiences and avoids reinforcing existing inequalities ^[11].

sbb-itb-535baee

Navigating Transparency and Trust With AI in Health Care

Legal and Regulatory Requirements for AI Consent

U.S. Regulations on AI in Healthcare

Navigating informed consent in AI-assisted healthcare is no small feat, especially as patient autonomy faces new complexities. In the U.S., regulations are still catching up, with oversight split across agencies like the FDA, CMS, and OMB. This fragmented framework creates challenges for consistent compliance ^[13][14].

The FDA has already authorized over 1,000 AI-enabled devices through its premarket pathways as of early 2025. Its draft guidance from January 2025 highlights the importance of transparency and addressing bias throughout the lifecycle of these devices. Troy Tazbaz, Director of the FDA’s Digital Health Center of Excellence, emphasizes:

The FDA has authorized more than 1,000 AI-enabled devices through established premarket pathways... it's important to recognize that there are specific considerations unique to AI-enabled devices ^[12].

OMB Memorandum M-25-21 also plays a role, requiring strict risk management and human oversight for high-impact AI systems. Meanwhile, state laws like Texas SB 1188, Illinois HB 1806, and CMS policies mandate that licensed professionals review AI-generated records and retain final decision-making authority. As CMS guidance makes clear:

AI should provide advice or recommendations; final decisions must be made by qualified staff with documented oversight ^[14].

Without federal regulations, states have stepped in with their own AI disclosure laws, creating a patchwork of requirements. This forces healthcare organizations operating across multiple states to navigate varying triggers, timelines, and standards.

State Law	Effective Date	Requirement
Texas TRAIGA (HB 149)	January 1, 2026	Clear and conspicuous disclosure when AI is used in care
Texas SB 1188	September 1, 2025	Practitioners must review AI-generated records for accuracy
California AB 3030	January 1, 2025	Disclaimers on GenAI clinical communications; instructions to contact a human
California AB 489	January 1, 2026	Prohibits AI from using professional credentials (MD, RN) without human oversight
Illinois HB 1806	August 2025	Disclosure required for AI in behavioral health; bans independent AI therapy
California SB 243	January 1, 2026	Mental health chatbots must disclose they are not human practitioners

Some laws, like Texas TRAIGA, include exceptions for emergencies where delays could endanger lives ^[13]. Penalties for violations can range from $10,000 to $200,000 per incident, as enforced by the Texas Attorney General ^[17].

Healthcare providers are responsible for ensuring that AI tools meet state-specific disclosure requirements, even when managing third-party AI risk within EHR-integrated systems. Vendors must also comply with these laws, particularly the "clear and conspicuous" disclosure standard, which requires real-time transparency at the point of interaction with patients ^[13][17].

Fraudulent use of AI has already led to legal action. In June 2025, the Department of Justice dismantled a scheme involving fake AI-generated recordings of Medicare beneficiaries, resulting in $703 million in fraudulent claims ^[18]. Later that year, a December 11 Executive Order proposed a "single national framework" to preempt state AI laws, adding uncertainty about the future of state-level consent requirements ^[17][18]. Until federal standards are finalized, healthcare organizations are advised to align with the strictest state laws to ensure compliance ^[13].

These developments in the U.S. reflect a broader, global conversation about AI consent and its complexities ^[13][14].

International AI and Patient Rights Regulations

Globally, AI regulations take a risk-based and patient-focused approach. The EU AI Act categorizes medical AI tools as "high-risk", requiring robust data governance and human oversight ^[16]. However, critics argue that the Act treats consent as a secondary obligation rather than a cornerstone of trust. Barry Solaiman, an advocate for an AI Bill of Rights, critiques this approach:

The AI Act builds trust by asking someone else to build trust later ^[15].

The GDPR also plays a critical role, classifying health data as sensitive and requiring explicit informed consent for its use in training AI algorithms or sharing it with external vendors ^[16]. Despite these safeguards, challenges remain. For example, a 2025 survey revealed that 76% of physicians used general-purpose large language models like ChatGPT for clinical tasks, yet many lacked clear guidelines on their use ^[16].

Generative AI used for non-medical purposes, such as administrative tasks, often falls outside the scope of the EU's Medical Device Regulation (MDR). This creates uncertainty around patient privacy and liability. A study of Dutch hospitals found that while 57% used generative AI, only 30% had formal policies in place ^[16].

In the UK, the Montgomery v. Lanarkshire ruling requires disclosure of any risks a "reasonable person" would find significant. Germany, on the other hand, mandates disclosure of all risks, even rare ones, that could influence an individual patient's decision ^[8]. A review of 132 legal cases across the U.S., UK, and Germany shows that existing legal principles can address AI's unique challenges if applied with the experimental nature of these tools in mind. Courts expect clinicians to inform patients when AI tools are in development or transitional phases, ensuring patients understand the associated uncertainties ^[7][8].

A proposed U.S. framework suggests categorizing AI tools into three groups - those requiring consent, notification, or neither - based on the risk of harm and the patient's ability to exercise autonomy. High-risk tools like diagnostic AI would require full consent, while lower-risk tools might only need notification. However, researchers warn of an "agency paradox": patients may struggle to process complex AI disclosures in clinical settings, yet they are expected to evaluate AI-generated outputs ^[1].

Stanford Law School suggests shifting the focus from individual disclosures to institutional accountability. By ensuring that experts assess algorithmic risks on behalf of patients, healthcare systems can build a stronger foundation for trust. This approach highlights the need for robust technical infrastructure to monitor AI performance across diverse patient populations. Together, U.S. and international regulations emphasize the importance of clear, accountable processes for AI consent in healthcare.

How to Build Transparent AI Consent Processes

Creating transparent AI consent processes is essential for meeting patient expectations and maintaining trust. A survey reveals that 54% of U.S. adults expect to give explicit permission for AI use, making it clear that consent frameworks need to be tailored to specific risks and clinical contexts rather than relying on generic, one-size-fits-all approaches ^[6].

Using Dynamic Consent Models for AI Tools

Traditional consent forms often assume a one-time agreement, but AI tools are constantly evolving. Dynamic consent models address this by letting patients review and update their preferences as AI systems change or as their treatment progresses. This approach acknowledges that patient comfort varies depending on the context - 35% of patients, for example, would withhold consent for AI use in mental health scenarios ^[2].

Dynamic consent models often rely on digital platforms like patient portals or mobile apps, allowing patients to adjust their consent settings anytime. Research shows that patients are more likely to consent when they receive detailed disclosures about data storage, corporate involvement, and AI training processes. This underscores the importance of making transparency an ongoing effort rather than a one-time checkbox during admission ^[2]. As Katharine Lawrence, MD, from NYU Grossman School of Medicine, explains:

The informed consent conversation is a critical but nuanced touchpoint that shapes the adoption and acceptance of technology by both clinicians and patients; flexible, multimodal approaches that include education, digital tools, and opt-out options may enhance engagement ^[2].

Organizations should adopt risk-based frameworks, distinguishing between high-risk clinical AI applications, which may require formal consent, and lower-risk administrative AI, which might only call for notification. For instance, 46% of patients want to give explicit permission for AI-assisted clinical notetaking, while 45% prefer the same for administrative tasks like billing or scheduling ^[6]. These dynamic consent models naturally lead to the need for simplifying how AI outcomes are communicated.

Making AI Decisions Easier to Understand

For dynamic consent to be meaningful, AI decisions must be explained in plain terms. Patients cannot provide informed consent if they don’t understand what they’re agreeing to. Studies show that patients are more comfortable with AI for routine tasks like documentation (63.1%) than for diagnostic support (30.1%) ^[2]. Transparency requires clear explanations of AI's role, such as its function, how data is stored, who has access, and how it’s used for training. Avoiding technical jargon is key. For example, instead of a complicated explanation, say: "This tool helps your doctor review your X-ray for signs of pneumonia, but your doctor makes the final diagnosis."

Transparency also involves addressing legal risks, particularly around data discoverability ^[2]. The University of Michigan's TIERRA program highlights the importance of notification and consent in maintaining public trust as AI tools become more integrated into healthcare ^[6]. Healthcare providers should establish clear protocols for notifying patients, ensuring transparency becomes a standard practice.

Training Clinicians to Communicate About AI

Even the best consent framework won’t work without clinicians who can clearly explain it. Healthcare professionals need training to discuss AI’s role, limitations, and risks in ways patients can easily understand. This includes addressing accountability concerns - 64.1% of patients hold physicians accountable for medical errors involving AI-assisted documentation, while 76.7% believe vendors should be responsible for data security breaches ^[2].

Clinicians should also be able to explain the "human-in-the-loop" approach, where AI recommendations are reviewed by qualified professionals before any clinical decisions are made. Training should prepare them to handle patient opt-outs without creating friction or making patients feel that refusing AI could compromise their care. As the University of Michigan Medical School advises:

Healthcare providers and policymakers should prioritize patient autonomy by implementing transparent AI disclosure practices that allow patients to understand when and how AI tools are being used in their care ^[6].

To support this, organizations should create standardized scripts and educational materials for clinicians to use during consent discussions. This ensures consistency across departments and reduces the burden on individual providers to explain complex AI systems. Clear communication, combined with dynamic consent frameworks, is the foundation for building trust in AI-enabled healthcare.

Using Censinet RiskOps for AI Consent and Risk Management

As patient rights and informed consent take center stage in healthcare, managing risks tied to AI tools is more critical than ever. This requires solutions that combine precision with transparency. Censinet RiskOps provides a centralized platform that simplifies AI risk management while supporting informed consent. By blending automated risk assessments with human oversight, it ensures AI tools meet regulatory standards and ethical guidelines.

RiskOps not only supports clear consent processes but also helps healthcare organizations stay compliant by streamlining risk evaluations and maintaining continuous oversight.

Faster Vendor Assessments with Censinet AITM

Evaluating AI vendors can often take weeks, slowing down the adoption of tools that could be transformative for patient care. Censinet AITM (AI Third-Party Management) speeds up this process significantly. With pre-built questionnaires and AI-driven scoring, the platform automates vendor risk assessments, cutting the timeline from 2–4 weeks to just 48 hours - a time savings of up to 80%^[19].

For example, when assessing an AI diagnostic imaging tool, Censinet AITM automates the completion of risk questionnaires based on vendor-provided disclosures. It flags potential data privacy concerns that could impact consent processes. By integrating with vendor portals, the platform evaluates risks in real time, enabling healthcare providers to make swift decisions. This ensures vendors meet key standards for data security, consent protocols, and bias mitigation before their tools are deployed in patient care.

Centralized AI Risk Dashboards for Continuous Monitoring

Deploying AI tools is just the beginning - ongoing monitoring is vital to ensure compliance with consent and regulatory requirements. The Centralized AI Risk Dashboard in Censinet RiskOps provides a real-time, unified view of all AI vendors and tools. This dashboard tracks compliance metrics, policy adherence, and consent-related data, giving healthcare organizations 100% visibility into AI compliance^[19].

The dashboard monitors critical indicators like vendor uptime, data usage logs, and regulatory updates. Alerts are triggered for deviations, such as when an AI tool's accuracy falls below 95%, prompting immediate action to update patient consent processes^[19]. These insights help governance teams stay on top of algorithmic changes that might affect how AI is explained to patients, ensuring consent remains informed. Key findings and tasks are routed to relevant stakeholders, like members of the AI governance committee, for timely review and approval. This robust monitoring system ensures that compliance is proactive, not reactive.

Human-in-the-Loop Oversight for Ethical AI Use

While automation can enhance efficiency, ethical AI deployment still requires human judgment - especially for high-stakes clinical decisions. Censinet incorporates a human-in-the-loop approach, combining automated risk monitoring with mandatory human reviews for processes involving sensitive consent decisions. This ensures that fully automated systems never operate without clinician oversight.

For instance, when AI predicts patient readmission risks, these predictions are reviewed by clinicians before being used in consent discussions. In one case, AI flagged certain patients as high-risk, but doctors adjusted recommendations after considering detailed patient histories. This ensured that consent discussions were based on accurate, human-verified information rather than solely on algorithmic predictions^[19]. Organizations using this approach have seen a 40% reduction in consent-related incidents, maintaining the benefits of automation while safeguarding ethical decision-making. Configurable rules and review processes allow risk teams to retain control, ensuring that automation complements rather than replaces critical human oversight in patient care and consent management.

Case Studies: AI Consent Successes and Failures

The contrast between successful and failed AI consent implementations offers valuable lessons for healthcare providers. These examples highlight the importance of transparency, patient trust, and thoughtful consent practices in AI-assisted care.

Examples of Effective AI Consent Practices

NYU Langone Health tested AI ambient documentation in 2024 with 121 participants. The results showed that 74.8% of patients were comfortable with its use, but their willingness to consent depended on trust in their clinician and the specific clinical setting. A multimodal approach - combining nonclinical staff support, digital tools, and clear opt-out options - proved more effective than verbal consent alone. Interestingly, when patients received detailed disclosures about AI features, data storage, and vendor involvement, consent rates dropped from 81.6% to 55.3%. This "transparency paradox" highlights the challenge of balancing openness with avoiding information overload ^[2].

Lifespan Health System utilized GPT-4 in September 2023 to simplify surgical consent forms, reducing the reading level to 6th grade and cutting word count by 25%. They employed a human-in-the-loop system where legal and medical experts reviewed all AI-generated content before use.

"With GPT-4, a problem that persisted for decades can now be solved in minutes. If we can help improve patient outcomes by simplifying consent forms, what else might be possible with AI?" - Dr. Fatima Mirza, Medical Resident, Lifespan ^[23]

UMass Chan Medical School demonstrated in February 2025 how AI could improve consent documentation. Using the Mistral 8x22B language model, they generated informed consent forms for clinical trials that outperformed human-drafted versions. The AI-generated forms scored 90.63% for understandability (compared to 67.19% for human versions) and 100% for actionability, while human-drafted forms scored 0% in this area ^[20].

These successes emphasize the importance of transparency, careful oversight, and adaptable consent strategies in AI-assisted healthcare.

Common AI Consent Mistakes and Their Consequences

Not all institutions have managed to navigate AI consent effectively, and some failures have led to serious consequences.

At Sharp HealthCare in San Diego, a major consent failure emerged in December 2025. A class-action lawsuit was filed against the health system for using an AI dictation tool, "Abridge", to record patient conversations without explicit consent. The rollout, which began in April 2025, reportedly involved staff marking patients as having consented without their actual agreement. The lead plaintiff, Jose Saucedo, discovered that his medical records included AI-generated notes falsely affirming his consent. Attorneys estimated that 100,000 patient encounters were recorded, with audio stored by the vendor for AI training purposes ^[21]. This case highlights the risks of AI tools automatically appending consent notes to medical records without proper patient agreement.

Another recurring issue is the "agency paradox." This occurs when organizations claim that patients are too overwhelmed to process detailed AI disclosures yet still expect them to act as quality-control agents for AI-generated summaries. This approach undermines patient autonomy and trust.

A precedent-setting case from the UK in 2015 also offers a cautionary tale. A hospital failed to inform patients about the limited safety data and the surgeon’s inexperience with a new surgical technique, Trans-anal Total Mesorectal Excision. The court ruled the consent process inadequate, emphasizing that patients must be informed of unknown risks and limited track records when experimental techniques - or AI tools - are involved ^[22].

These examples underscore the critical need for clear communication, explicit disclosure of risks, and rigorous consent practices to maintain patient trust and avoid legal pitfalls.

Conclusion: Protecting Patient Rights in AI-Assisted Healthcare

Bringing AI into healthcare demands more than just innovation - it requires transparency, strong human oversight, and a steadfast commitment to patient autonomy. Success in this area hinges on pairing AI with ethical safeguards and ensuring clear, meaningful communication with patients. Instead of overwhelming individuals with technical jargon or superficial consent procedures, the focus should be on providing disclosures that truly matter.

It's not enough for healthcare organizations to assume that having a human in the loop will catch every AI error. As researchers from Stanford Law School CodeX emphasize:

The premise that human oversight will 'successfully detect errors' is precisely the premise that automation bias scholarship has spent two decades dismantling ^[1].

As discussed earlier, technical audits and ongoing oversight are critical to complement human judgment. True protection for patients requires active institutional accountability, including regular technical evaluations, monitoring for bias, and training clinicians to understand AI's limitations.

The key lies in prioritizing materiality over complexity. Patients have the right to understand when AI is involved in their care and what risks are relevant to their decisions - without needing a technical background. The World Health Organization underscores this point:

The use of machine-learning algorithms in diagnosis, prognosis and treatment plans should be incorporated into the process for informed and valid consent ^[3].

This means focusing on the risks and information that a reasonable patient would find important, rather than burying them in unnecessary technical details. To uphold this principle, healthcare organizations must implement reforms that actively support patient rights.

The current gap between widespread AI adoption and robust governance highlights the urgent need for better risk management systems. These systems should identify new risks as they arise and ensure compliance with ethical standards. Ultimately, safeguarding patient rights in AI-assisted healthcare comes down to building a framework rooted in trust, transparency, and patient-centered care. When organizations emphasize these values - through dynamic consent models, effective human oversight, and strong risk management - they not only meet regulatory standards but also strengthen the therapeutic relationship and empower patients to make informed decisions about their care.

AI holds tremendous promise in healthcare, but its success must always rest on trust, transparency, and a commitment to putting patients first.

FAQs

When do I have to consent vs just be notified about AI?

In the realm of AI-assisted healthcare, informed consent is generally necessary when AI is involved in situations that could impact patient safety, autonomy, or privacy - like making diagnostic or treatment decisions. For administrative tasks or low-risk uses that don’t influence clinical outcomes, a simple notification might be enough. Healthcare providers should carefully assess the AI's function, potential risks, and applicable state laws to decide if consent is required, always keeping transparency and patient autonomy at the forefront.

What should I ask to spot AI bias in my care?

To spot potential AI bias in healthcare, start by questioning whether the system might result in unequal treatment, particularly for underrepresented groups. Ask if steps have been taken to evaluate fairness and ensure transparency. It's also important to find out if a diverse group of stakeholders contributed to the system’s development. Lastly, confirm whether regular bias assessments are performed to maintain fair and equitable outcomes for all patients.

Can I opt out of AI without affecting my treatment?

Yes, you can usually choose to opt out of AI-assisted care without it affecting the quality of your treatment. Healthcare providers are obligated to respect patient autonomy, obtain informed consent, and inform you when AI is involved in your care. If you decide against using AI-supported services, your decision should be honored.

Related Blog Posts

• The AI Risk Iceberg: What Lies Beneath the Surface of Machine Learning Deployments
• The Psychology of AI Safety: Understanding Human Factors in Machine Intelligence
• Digital Doctors: The Promise and Peril of AI in Clinical Decision-Making
• Clinical Intelligence: Using AI to Improve Patient Care While Managing Risk